Unibest

Pharmaceutical intermediates

Brinzolamide Intermediates

2 pharmaceutical intermediates for Brinzolamide. Indication: Ocular hypertension; Open-angle glaucoma.

提交项目All intermediates

About Brinzolamide

Originator
Alcon Laboratories, Inc.
Indication
Ocular hypertension; Open-angle glaucoma
Approved Date
04/01/1998
DS/DP
06/17/2030

Available intermediates

2 intermediates currently listed for Brinzolamide. Request specifications, documentation or a quotation for any item below.

Brinzolamide intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(S)-3,4-dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide160982-16-1//
(S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide154127-42-1//

Other programs under B

Baloxavir MarboxilBaricitinibBDTX-1535Bedaquiline FumarateBelumosudil mesylateBelzutifanBempedoic acidBeraprost Sodium

Building toward Brinzolamide?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →